Holen Sie sich die Stockscreener-App
0.8882
2.93%
-0.0268
Schlusskurs vom Vortag:
$0.915
Offen:
$0.91
24-Stunden-Volumen:
201.62K
Relative Volume:
0.56
Marktkapitalisierung:
$13.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.51M
KGV:
-0.6729
EPS:
-1.32
Netto-Cashflow:
$-8.02M
1W Leistung:
-16.21%
1M Leistung:
-11.18%
6M Leistung:
-34.21%
1J Leistung:
-30.61%
1-Tages-Spanne:
$0.865
$0.9396
1-Wochen-Bereich:
$0.865
$1.07
52-Wochen-Spanne:
$0.6554
$2.115
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Firmenname
Hoth Therapeutics Inc
Sektor
Branche
Telefon
(646)756-2997
Adresse
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Vergleichen Sie HOTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
0.8882 | 14.20M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.90 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.45 | 78.77B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
840.50 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
338.06 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.38 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-15 | Eingeleitet | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Aktie (HOTH) Neueste Nachrichten
Risk Analysis: Can BSVN expand into new marketsMarket Activity Report & Verified Stock Trade Ideas - baoquankhu1.vn
Market Trends: Whats the outlook for Hoth Therapeutics Incs sectorGDP Growth & Verified Short-Term Plans - baoquankhu1.vn
Pharma News: What are the risks of holding Aduro Clean Technologies IncMarket Weekly Review & AI Forecast Swing Trade Picks - baoquankhu1.vn
Bear Alert: Can National Energy Services Reunited Corp Equity Warrant keep up with sector leaders2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Hoth reports positive interim results for cancer skin therapy By Investing.com - Investing.com Nigeria
Hoth Therapeutics Early Cancer Trial Succeeds With 100% Patient Response, Cuts Disease Severity By Half - Benzinga
Hoth Therapeutics stock rises after positive interim trial results By Investing.com - Investing.com South Africa
Hoth Therapeutics stock rises after positive interim trial results - Investing.com
Hoth reports positive interim results for cancer skin therapy - Investing.com
Cancer patients on EGFR drugs report less toxicity and itch with HT-001 - Stock Titan
Hoth Therapeutics secures Chinese patent for cancer cell therapy By Investing.com - Investing.com Nigeria
Hoth Therapeutics gains after winning China patent for HT-KIT cancer program - MSN
Sell Signal: What’s the outlook for Hoth Therapeutics Inc.’s sector2025 Price Action Summary & Expert Verified Movement Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Hoth Therapeutics stock rises after securing Chinese patent for cancer therapy By Investing.com - Investing.com Australia
Hoth Therapeutics stock rises after securing Chinese patent for cancer therapy - Investing.com Nigeria
Hoth Therapeutics secures Chinese patent for cancer cell therapy - Investing.com
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position - PR Newswire
Aug Analyst Calls: Can Salarius Pharmaceuticals Inc continue delivering strong returnsJuly 2025 Patterns & High Conviction Investment Ideas - baoquankhu1.vn
Why Hoth Therapeutics Inc. stock could outperform in 2025July 2025 Review & Low Drawdown Investment Strategies - bollywoodhelpline.com
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% - MSN
Hoth Therapeutics highlights obesity and pipeline progress to regulators - TipRanks
Hoth Therapeutics, Inc. Presents New Drug Development Initiatives - TradingView — Track All Markets
Hoth Therapeutics receives positive EU regulatory decision for cancer trial By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Cancer trial to test topical drug for skin side effects from therapy - Stock Titan
Hoth Therapeutics receives positive EU regulatory decision for cancer trial - Investing.com
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing Ht-001 Oncology Trial Toward Multi-Country Site Activation - TradingView
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation - PR Newswire
Is Hoth Therapeutics Inc stock trending bullishPortfolio Performance Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Published on: 2026-01-14 02:28:37 - baoquankhu1.vn
Gap Down: What Wall Street predicts for Hoth Therapeutics Inc stock priceJuly 2025 Technicals & Real-Time Buy Zone Alerts - Bộ Nội Vụ
Growth Value: Is Hoth Therapeutics Inc. stock supported by innovation pipelineEarnings Growth Report & Risk Managed Investment Signals - Улправда
Big Money Moves: Why Hoth Therapeutics Inc. stock could outperform in 2025Trade Analysis Summary & Fast Momentum Stock Entry Tips - ulpravda.ru
Why Hoth Therapeutics Inc. stock remains resilient2025 Momentum Check & Free Long-Term Investment Growth Plans - Улправда
Can Hoth Therapeutics Inc. stock weather global recessionWeekly Stock Report & Risk Controlled Daily Plans - Улправда
Will Hoth Therapeutics Inc. stock beat EPS estimatesJuly 2025 Spike Watch & Breakout Confirmation Trade Signals - Улправда
Volume Summary: Why Hoth Therapeutics Inc. stock could outperform in 2025Portfolio Return Report & Safe Capital Growth Tips - ulpravda.ru
Hoth Therapeutics Files Dual U.S. Provisional Patents to Expand Oncology Dermatology IP - Digital Health News
Hoth Therapeutics Files Two Provisional Patents To Build Oncology Dermatology Platform - Nasdaq
Hoth Therapeutics Files Two US Provisional Patents for Oncology-Focused Dermatology Platform; Shares Rise - marketscreener.com
Hoth Therapeutics Files New Patents to Expand Oncology Dermatology Platform - Contract Pharma
Hoth therapeutics files patents for oncology skin toxicity treatments By Investing.com - Investing.com Canada
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments - Investing.com Nigeria
Hoth Therapeutics stock rises after filing patents for cancer therapy skin toxicity treatments By Investing.com - Investing.com South Africa
Finanzdaten der Hoth Therapeutics Inc-Aktie (HOTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):